Cancer Immunotherapy Market Size to reach $101.6 billion at 14.8% CAGR by 2023. Surging prevalence of cancer and soaring lifestyle diseases to Spur Global Cancer Immunotherapy Market Growth. Global Cancer Immunotherapy Market Analysis By Type of Therapy (Monoclonal Antibodies, Adoptive Cell Transfer and others), Application (Lung Cancer, Childhood Cancer and other), End User (Hospitals, Clinics & others) – Forecast till 2023
The players dominating the global cancer immunotherapy market includes Merck & Co., Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline Plc., Novartis International AG, Bristol-Myers Squibb, Amgen Inc., Celgene Corporation, ELI Lilly and Company, Spectrum Pharmaceuticals, Inc., and Seattle Genetics, Inc.
Get Free Sample “Global Cancer Immunotherapy Market 2019 Report” at: https://www.marketresearchfuture.com/sample_request/567
Global Cancer Immunotherapy Market Overview:
The cancer immunotherapy market is anticipated to surpass a valuation of USD 101.6 billion, attaining a CAGR of 14.8% during the forecast period (2016-2023), Market Research Future (MRFR) unveils in a detailed report. Cancer Immunotherapy Market: North America to Dominate the Market
The global cancer immunotherapy market is gaining huge attention across the globe. The market has been growing at an impressive rate in the recent past and is predicted to retain the same in the foreseeable future. Cancer immunotherapy enables the immune system to target cancerous tumor cells. Due to deteriorating lifestyle, alcoholism and smoking have increased tremendously, which is highly responsible for cancer. Immunotherapy is high in demand due to increasing cancer population across the globe. This therapy is highly effective and has fewer side effects compared to other therapies, which trigger its demand across the globe. Moreover, immunotherapy is highly effective for patients who have melanoma cancer when other radiation therapies and chemotherapy do not work. Such benefits have increased its demand across the globe.
On the contrary, the dearth of awareness and the adverse related to immune therapeutic drugs are likely to restrict the growth in the foreseeable future. On a brighter note, the soaring number of immunotherapeutic drug classes, specifically the target receptors for checkpoint inhibitors and multiple myeloma will encourage the market growth.
Global Cancer Immunotherapy Market: Segmental Analysis
By therapy type, the cancer immunotherapy market is segmented into adoptive cell transfer, monoclonal antibodies, treatment vaccines, cytokines, bacillus Calmette-guérin, and others. Of these, the monoclonal antibodies segment were the most prominent ones. The growth can be credited to the soaring investments in R&D as naked antigen-binding antibodies, bispecific antibodies, conjugated monoclonal antibodies, which have opened new avenues for revenue generation. The R&D activities are further resulting in the advent of mAbs, which have effects like antigen specificity, adaptive immunity, and antibody-dependent cellular toxicity.
By application, the cancer immunotherapy market is segmented into childhood cancer, liver cancer, stomach cancer, colorectal cancer, lung cancer, and others. Of these, the lung cancer segment is predicted to gain prominence due to the soaring prevalence of cancer across the globe.
By end user, the market comprises hospitals, clinics, and others. Of these, the hospital’s segment captures the highest share as a large number of patients are treated in hospitals for cancer immunotherapy.
Regional Analysis:
Geographically, the cancer immunotherapy market spans across Europe, North America, Asia Pacific, and the Middle East & Africa.
Considering the global scenario, Europe and North America are considered to be the major contributors to the global market. The growth is mainly due to its reputation as a suitable place for R&D. The cancer immunotherapy market has a tremendous demand in both the regions, which is further expected to propel the market growth in the foreseeable future. North America dominates the market, and the growth is mainly supported by the radiotherapy market in the U.S., which is evolving owing to the presence of a large patient population in the region. The market in Europe is emerging rapidly due to the soaring number of cancer patients in the region. The proliferation of advanced treatment facilities, coupled with the availability of skilled professionals and support from the government for R&D are some of the major driving factors.
The Asia Pacific is considered the fastest expanding market due to the existence of rapidly evolving healthcare technology, soaring expenditure on healthcare, and the presence of a huge patient pool. The surging demand for latest and innovative treatment methods in economies like South Korea and India are estimated to propel the regional market’s growth. Factors such as the surging prevalence of cancer and the proliferation of the latest treatment methods are augmenting the market growth.
Industry Updates:
July 2019: An all-new immunotherapy treatment for advanced skin cancer patients will be made available on the NHS in England. The decision came into action right after the drug received European approval. Patients in England will be among the first to receive the treatment and will be paid for by the Cancer Drugs Fund.
Table Of Content
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
- Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
- Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
- Global Cancer Immunotherapy Market, By Therapy Type
6.1 Introduction
6.2 Monoclonal Antibodies
6.2.1 Market Estimates & Forecast, 2017-2023
6.3 Adoptive Cell Transfer
6.3.1 Market Estimates & Forecast, 2017-2023
6.4 Cytokines
6.4.1 Interferon (INFs)
6.4.2 Interleukins (ILs)
6.4.3 Market Estimates & Forecast, 2017-2023
6.5 Treatment Vaccines
6.5.1 Market Estimates & Forecast, 2017-2023
6.6 Bacillus Calmette-Guérin
6.6.1 Market Estimates & Forecast, 2017-2023
6.7 Others
- Global Cancer Immunotherapy Market, By Application
7.1 Introduction
7.2 Liver Cancer
7.2.1 Market Estimates & Forecast, 2017-2023
7.3 Childhood Cancer
7.3.1 Market Estimates & Forecast, 2017-2023
7.4 Colorectal Cancer
7.4.1 Market Estimates & Forecast, 2017-2023
7.5 Stomach Cancer
7.5.1 Market Estimates & Forecast, 2017-2023
7.6 Lung Cancer
7.6.1 Market Estimates & Forecast, 2017-2023
7.7 Others
- Global Cancer Immunotherapy Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Market Estimates & Forecast, 2017-2023
8.3 Clinics
8.3.1 Market Estimates & Forecast, 2017-2023
8.4 Others
Continued…
LIST OF TABLES:
Table 1 Cancer Immunotherapy Industry Synopsis, 2017-2023
Table 2 Global Cancer Immunotherapy Market Estimates And Forecast, 2017-2023, (USD Million)
Table 3 Global Cancer Immunotherapy Market By Region, 2017-2023, (USD Million)
Table 4 Global Cancer Immunotherapy Market By Therapy Therapy Types, 2017-2023, (USD Million)
Table 5 Global Cancer Immunotherapy Market By Application, 2017-2023, (USD Million)
Table 6 Global Cancer Immunotherapy Market By End Users, 2017-2023, (USD Million)
Continued…
LIST OF FIGURES:
Figure 1 Research Process
Figure 2 Segmentation For Global Cancer Immunotherapy Market
Figure 3 Segmentation Market Dynamics For Cancer Immunotherapy Market
Figure 4 Global Cancer Immunotherapy Market Share, By Type 2016
Figure 5 Global Cancer Immunotherapy Market Share, By Application 2016
Figure 6 Global Cancer Immunotherapy Market Share, By End Users, 2016
Figure 7 Global Cancer Immunotherapy Market Share, By Region, 2016
Figure 8 North America Cancer Immunotherapy Market Share, By Country, 2016
Figure 9 Europe Cancer Immunotherapy Market Share, By Country, 2016
Figure 10 Asia Pacific Cancer Immunotherapy Market Share, By Country, 2016
Figure 10 Middle East & Africa Cancer Immunotherapy Market Share, By Country, 2016
Continued…
Browse more information at: https://www.marketresearchfuture.com/reports/global-cancer-immunotherapy-market-567
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Company Name: Market Research Future
Email: sales@marketresearchfuture.com
Phone: +1 646 845 9312
Country: India
Website: www.marketresearchfuture.com
